CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Betalin is developing the Micro Pancreas, a biologic implant designed to restore insulin production in diabetes patients. This innovative solution aims to eliminate the need for daily insulin injections and improve glucose regulation, significantly enhancing patients' quality of life.
Diabetes is a constantly growing concern in Europe and worldwide.
Patients with Diabetes suffer from lack of insulin production.
Without it, glucose remains in the blood and causes significant complications that can be both short term -seizures and fainting that could result in coma or even death, and long-term - stroke, heart disease, blindness, kidney failure and limb amputation.
Betalin is developing a biologic cure to Diabetes: the Micro Pancreas that after implantation under the skin (by in…
BETALIN THERAPEUTICS LTD
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United Kingdom, Leeds
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
